Administration of nCVF to hemophilia A and WT mice prior to fVIII exposure failed to significantly alter very early anti-fVIII antibody formation compared to controls, although effective complement depletion could certainly impact later anti-fVIII antibody formation in this setting. Here, F8 is linked to hemophilia A.